Sign inGet started

MALLIK AMEET

Insider CIK 1861441 · ATRA Director · RFL CHIEF EXECUTIVE OFFICER, Director · ADCT Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ADCT ADC Therapeutics SA A Award2026-06-302026-07-02675,000— $02,121,769SEC↗
ADCT ADC Therapeutics SA A Award2026-02-132026-02-18900,000$3.99 $3.59M1,550,000SEC↗
ADCT ADC Therapeutics SA F Tax w/h2026-02-132026-02-18103,231$3.99 $411.9K1,446,769SEC↗
ADCT ADC Therapeutics SA F Tax w/h2025-12-062025-12-09233,146$3.29 $767.1K1,319,101SEC↗
ATRA Atara Biotherapeutics, Inc A Award2025-06-102025-06-127,828— $016,928SEC↗
ADCT ADC Therapeutics SA F Tax w/h2025-05-062025-05-0826,758$1.29 $34.5K1,552,247SEC↗
ADCT ADC Therapeutics SA A Award2025-02-132025-02-14650,000$1.61 $1.05M1,579,005SEC↗
ADCT ADC Therapeutics SA F Tax w/h2024-12-062024-12-09238,343$3.13 $746.0K929,005SEC↗
ADCT ADC Therapeutics SA S Sale2024-05-072024-05-0929,731$4.48 $133.2K1,167,348SEC↗
ATRA Atara Biotherapeutics, Inc A Award2024-03-312024-04-02150,000— $0227,500SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2023-05-312023-06-0279,500— $079,500SEC↗
ATRA Atara Biotherapeutics, Inc A Award2023-05-312023-06-0257,000— $077,500SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2022-06-232022-06-2731,500— $031,500SEC↗
ATRA Atara Biotherapeutics, Inc A Award2022-06-232022-06-2720,500— $020,500SEC↗
RFL Rafael Holdings, Inc. D To issuer2022-02-012022-04-12908,497— $00SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2021-08-092021-08-1055,000— $055,000SEC↗
RFL Rafael Holdings, Inc. A Award2021-05-272021-05-28908,497$44.70 $40.61M908,497SEC↗